Literature DB >> 22001878

Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation.

F Silveira1, S P Cibulski, A P Varela, J M Marqués, A Chabalgoity, F de Costa, A C A Yendo, G Gosmann, P M Roehe, C Fernández, F Ferreira.   

Abstract

In this study, a preparation of saponins (QB-90U) extracted from leaves of Quillaja brasiliensis collected in Uruguay was evaluated as a vaccine adjuvant by comparison with alum and the well known saponin-based adjuvant, Quil A. The haemolytic activity and cellular toxicity of the saponin preparations were also evaluated. QB-90U was only slightly haemolytic and showed a low cytotoxicity when compared to Quil A. The adjuvant properties of QB-90U were assayed by sub-cutaneous immunization of mice with a preparation of inactivated bovine herpesvirus 5 (BoHV-5) either with no adjuvant or adjuvanted with QB-90U, Quil A or alum. Serum levels of anti-BoHV-5 IgG, IgG1, IgG2a, IgG2b and also IgG3 were significantly increased by QB-90U and were of the same order as those elicited by Quil A. Furthermore, high titres of neutralizing antibodies were found to be present in the serum of immunized animals from both groups. The cellular response induced by QB-90U did also reproduce the one elicited by Quil A. In fact, a robust DTH response was observed in mice immunized with both saponin preparations; as well as increased splenocytes levels of Th1-type cytokines, namely IFN-γ and IL-2. Taken together, the above results confirm and extend our previous observation regarding the similarity of the responses elicited by Quil A and the saponin preparation from Q. brasiliensis (Fleck et al., 2006) and indicate that QB-90U is worth of further studies as a safe and potent vaccine adjuvant. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001878     DOI: 10.1016/j.vaccine.2011.09.137

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Hemolytic and cytotoxic properties of saponin purified from Holothuria leucospilota sea cucumber.

Authors:  Mozhgan Soltani; Kazem Parivar; Javad Baharara; Mohammad Amin Kerachian; Javad Asili
Journal:  Rep Biochem Mol Biol       Date:  2014-10

Review 2.  Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus.

Authors:  Arbind Kumar; Aashish Sharma; Narendra Vijay Tirpude; Yogendra Padwad; Vipin Hallan; Sanjay Kumar
Journal:  Pharmacol Rep       Date:  2022-09-20       Impact factor: 3.919

3.  Preparation and efficacy of freeze-dried inactivated vaccine against bovine viral diarrhea virus genotypes 1 and 2, bovine herpes virus type 1.1, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus.

Authors:  Maha Raafat Abd El Fadeel; Ashraf Taha El-Dakhly; Ahmad Mohammad Allam; Tarek Korany Farag; Alaa Abdel-Moneim El-Kholy
Journal:  Clin Exp Vaccine Res       Date:  2020-07-31

4.  Structure Elucidation of Triterpenoid Saponins Found in an Immunoadjuvant Preparation of Quillaja brasiliensis Using Mass Spectrometry and 1H and 13C NMR Spectroscopy.

Authors:  Federico Wallace; Carolina Fontana; Fernando Ferreira; Cristina Olivaro
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

5.  Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responses.

Authors:  Fernanda de Costa; Anna Carolina A Yendo; Samuel P Cibulski; Juliane D Fleck; Paulo M Roehe; Fernando R Spilki; Grace Gosmann; Arthur G Fett-Neto
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

6.  Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and Splenocyte Proliferation.

Authors:  Samuel Cibulski; Ana Paula Muterle Varela; Thais Fumaco Teixeira; Martín Pablo Cancela; Patrícia Sesterheim; Diogo Onofre Souza; Paulo Michel Roehe; Fernando Silveira
Journal:  Front Immunol       Date:  2021-03-04       Impact factor: 7.561

7.  ISCOM-Matrices Nanoformulation Using the Raw Aqueous Extract of Quillaja lancifolia (Q. brasiliensis).

Authors:  Samuel Cibulski; Fernando Silveira; Thalisson Amorim de Souza; Joanda Paola Raimundo; Yuri Mangueira Nascimento; Lucas Silva Abreu; Norma Suarez; Iris Miraballes; Paulo Michael Roehe; Demetrius Antonio Machado de Araújo; Josean Fechine Tavares; Marcelo Sobral da Silva
Journal:  Bionanoscience       Date:  2022-08-06

8.  Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses.

Authors:  Samuel Paulo Cibulski; Mariana Rivera-Patron; Gustavo Mourglia-Ettlin; Cecilia Casaravilla; Anna Carolina Alves Yendo; Arthur Germano Fett-Neto; José Alejandro Chabalgoity; María Moreno; Paulo Michel Roehe; Fernando Silveira
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.